Tuesday, September 30, 2014

Will MERS Ruin This Year’s Hajj Pilgrimage?

Will an emerging viral disease ruin this year’s Hajj proceedings?

By:Ringo Bones 

Even though it was discovered near the end of 2012, Saudi authorities were criticized for its delayed handling of MERS – Middle Eastern Respiratory Virus – which is also prevalent across the UAE, Qatar, Kuwait, etc. and now threatens to disrupt the 2014 Hajj pilgrimage. Given the relatively “silent” spread of the virus, it was only as recently as July 2013 that the structure and histology of the MERS virus was fully documented.

Caused by a coronavirus called MERS-CoV which in humans will result in severe acute respiratory illness, symptoms of which includes cough and shortness of breath and in the advanced stages of the disease results in severe pneumonia and kidney failure. About 30 percent of people confirmed to have MERS-CoV infection have died. As of the middle of September 2014, there are 855 cases of MERS-CoV worldwide and 333 deaths so far. The virus was traced back to camels, but the way Middle Eastern public health authorities “downplayed” the urgency of the risk of the virus – which was way cavalier in comparison to the way public health authorities in East Asia handled the 2003 SARS coronavirus outbreak – resulted in the sacking of various health officials that included the health minister of Saudi Arabia which was personally sacked by HRS The King of Saudi Arabia himself for downplaying the risk of the MERS outbreak since 2013.

Due to the recent public health revamp, hospitals in Saudi Arabia has since taken more sensible precautions to avoid inadvertently spreading the MERS-CoV virus by having their nurses and other medical personnel to wash with disinfectant soaps before seeing other patients while doing their rounds on suspected MERS virus infected patients. Due to the increased urgency, Prof. Tariq Madani – the Saudi government’s scientific advisor on MERS recently spoke to the BBC back in the middle of September of 2014 that even though they still currently know very little of the MERS-CoV virus, safeguards are already implemented to avoid the spread of the virus during the upcoming Hajj pilgrimage in Mecca which is slated to greet a little over 2-million pilgrims this year. And Saudi Arabia’s acting health minister Adel Bin Muhammad Fakeih are urging camel merchants on the outskirts of Jeddah to take the necessary precautions on wearing masks and gloves when handling their camels. Though the camel merchants across the Middle East are still adopting a cavalier attitude when it comes to taking the necessary precautions against the MERS virus.

Even though Saudi Arabia’s public health authorities are doing the best they can to tackle the current MERS outbreak, the world narrowly averted a similar pandemic of a relatively unknown virus that was killing horses and their trainers in Australia during the mid-1990s. Back in September 1994, health authorities in Australia were worried. More than a dozen prize racehorses at the Hendra stables, outside of Brisbane in Australia’s northeast, were ill, running temperatures of up to 41 degrees Celsius. The animals had difficulty breathing and were emitting a bloody froth from their mouths and noses. Some began to die a ghastly, wheezing death. Within days, the worst fears of the public health authorities were realized: both the trainer and his stable-hand had collapsed, also suffering from respiratory problems.

The symptoms matched those of the African horse virus, or of equine influenza, both of which could spread from the Hendra stables and wreak havoc across Australia. But the infection of the two men raised another, more sinister possibility – that the health authorities were dealing with an unknown organism not only fatal to horses, but also capable of affecting humans as well.

Samples of horse spleen, lung and blood were sent to the Australian Animal Health Laboratory in Geelong – an imposing concrete structure outside Melbourne that houses one of the world’s most advanced infectious disease centers. Blood samples were from the two infected men were also rushed to the infectious diseases “hot labs” of Melbourne Fairfield Hospital and to the Centers for Disease Control and Prevention in Atlanta, Georgia, U.S.A.

Electron microscopy later revealed that the virus grown in the media had similarities with a large family of viruses called Paramyxoviridae, which includes measles, canine distemper and a then newly identified disease first seen to affect seals back in 1994, But it had an array of protrusions like no other paramyxovirus and no Paramyxoviridae are known to cause serious disease in both horses and humans. Not long after, scientists in Brisbane also isolated a virus which matched that found by the Geelong group. Sadly though the trainer died and equine morbillivirus still flare up time and time again in that region, the virus’s relatively high fatality rate seems to be its own containment mechanism that prevents equine morbillivirus from becoming a global pandemic.

Wednesday, August 27, 2014

Can The Ebola Epidemic Be Stopped?


Even though we know more about the virus – and recently developed newfangled cures – when we first discovered it back in the 1970s, but will we be able to control the spread of the Ebola virus? 

By: Ringo Bones 

The Ebola virus’ co-discoverer David Heymann was quite optimistic in a recent press interview that it is not yet too late to stop the spread of Ebola. The medical community even managed to just recently develop a novel cure against the virus that saved the lives of two American doctors that volunteered in the area where the recent Ebola outbreak – as in the 2014 Ebola outbreak - flared up. And even though we have a lot more to be optimistic about compared to 19 years ago when the last major epidemic of the virus occurred, can the Ebola epidemic ever be stopped? 

Part of the problem of developing an effective and / or practical cure against Ebola is due to the fact that it is a relatively recently discovered virus. Filoviruses – a family of viruses where Ebola belongs – were utterly unknown before 1967, where the first member of the family, Marburg virus, arrived in Germany in a shipment of African green monkeys. While the Marburg virus appears less dangerous to humans than the worst forms of Ebola, it shares a number of peculiarities with its more lethal cousin, including a puzzling mode of interaction with the human immune system. For reasons not yet clear, animals – and this include laboratory animals – infected with a filovirus typically seem not to become immune to it for long, which make it hard to imagine and effective vaccine or other forms of cure. 

The first ever documented major outbreak of Ebola happened back in 1976 in Zaire where the pathology of the virus was first discovered. It was the 1995 Ebola outbreak in Zaire that first raised global concern and concerted research for the cure of the disease. The fatality rate of the disease approached 90-percent, though horrendous to the infected, it’s the very characteristic of Ebola that limits its spread – i.e. infected individuals die before they can pass on the disease. The only consolation is that the Ebola virus is relatively hard to transmit, apparently requiring either exposure to infected blood products or very close contact with a sick individual. 

ZMapp drug has just recently proving its effectiveness in curing the early stages of Ebola after an American health worker working in Liberia named Kent Brantly received the first dose of the drug nine days after falling ill. ZMapp drug is being developed by Mapp Biopharmaceutical, Inc. ZMapp is composed of three humanized monoclonal antibodies (mAbs) that combine the best components of MB-033 (Mapp) and ZMab (Defyrus /PHAC) each of which were combinations of mAbs.  

Even though the latest monoclonal antibody based Ebola cure called ZMapp proved to be very effective in curing Ebola, it is quite expensive and slow to manufacture because its production involves farming / as in “pharming” its active components from a genetically modified tobacco plant and is still largely untested. Not surprising since the company who developed it is so small it is only composed of nine individuals. Given our current lack of knowledge on the nature of filoviruses, it might be awhile before medical science can develop an Ebola vaccine that is as inexpensive and as effective as the polio vaccine currently in widespread use. 

Tuesday, July 29, 2014

Norovirus: A Looming Public Health Threat?



Given that this “stomach flu virus” makes 20 million people fall ill to it just in America alone, is the norovirus the greatest public health threat to the global restaurant industry? 

By: Ringo Bones 

Even the exemplar hygiene standards of America’s Italian restaurants – given they are statistically the least likely to give their customers food borne illnesses in a recent study – whenever that rare but inevitable food born illness incidence finally occurs, chances are it is caused by the norovirus, commonly known as the “stomach flu virus” or gastroenteritis in people. Primarily spread whenever restaurant workers still report to work even if they are sick with the virus and therefore have a full-blown infection of the virus because they badly need the money that they can’t avoid to skip reporting to work and recuperate at home just because of a bearable yet very contagious viral infection. Given the prevailing austere economic environment of America and the rest of the world, will norovirus infections in major metropolitan areas across the world likely to reach epidemic proportions sooner rather than later? 

Given the notoriety of most restaurant proprietor’s inability to compensate their workers during sick leave – even mandatorily required ones by prevailing public health codes – norovirus “stomach flu” or gastroenteritis incidences across America’s major metropolitan areas and the rest of the world could reach epidemic proportions. Making norovirus the current least discussed public health threat by policymakers. Lack of proper sick leave compensation is the very reason why the norovirus is currently very prevalent in the United State’s restaurant industry since the September 2008 global financial crisis. 

Thursday, June 5, 2014

Latest Ageing Reverse Research: Fountain of Youth Finally Found?



Did the latest anti-aging research finally discover the proverbial “Fountain of Youth” in the blood plasma of younger organisms? 

By: Ringo Bones 

Since Spanish explorers had been searching for the Fountain of Youth in 16th Century America without signs of success, contemporary medial science have since written off studies into physiological age-reversing as nothing more than a “Quixotic Task”, but not anymore. Research authors of an ongoing study on age-reversing in the United States’ West and East coasts are finally confident of their latest results showing that they might be a way to physiologically reverse the biological aging process. 

Saul Villeda, Ph.D. of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research – one of the research authors of an ongoing research done on the US West and East coast on injecting blood plasma from younger mice into the hippocampuses of older mice have shown to reverse most of the damage done by Alzheimer’s Disease. Dr. Tony Wyss-Coray of Stanford University School of Medicine – one of the scientists involved in the Ageing Reverse Research – have experimental results showing older mice becoming stronger both physically and mentally after injecting their hippocampuses with blood plasma from much younger mice suggests that “younger blood plasma” recharges the brain. Though to the layman, the research results could suggest the physiological explanation of “vampirism”. 

Despite the research results suggesting the physiological explanation of “vampirism” and of “Bram Stroker’s Dracula”, repeatable lab results have shown that blood plasma of younger mice shows an observable improvement of the brains of older mice compared to the control group. Stronger reaction in the improved performance of the hippocampuses – the part of the brain involver in learning and memory - of older mice injected with blood plasma of younger mice suggests that the procedure could serve as a possible cure in reversing the damage done by Alzheimer’s to the brains of affected humans. The encouraging results point to the possibility of human trials in a few years time.

Wednesday, June 4, 2014

Post Orgasmic Illness: Spoiling Men’s Enjoyment of Sex?



Though the disorder is still extremely rare, is post orgasmic illness inadvertently spoiling men affected with it their full enjoyment of sex? 

By: Ringo Bones 

There is now a Facebook and other social network communities of men affected by the disorder and although it is still exceedingly rare, more and more men are now coming out as being affected by post orgasmic illness and how it spoils their maximum enjoyment of sex. But is the global medical science community currently working on the cure of such a terrible disorder?
Post orgasmic illness produces a flu-like symptom to men affected by it that lasts from two days to a few weeks depending on the severity. Rare as its occurrence may be, there might be a physiological explanation on why some men are affected by illness. They might be allergic to their own sperm since the symptoms of the illness tends to happen minutes after these men achieve orgasm and depending on severity, will give then flu-like symptoms that lasts for two days to three weeks. 

The allergen mechanism of post orgasmic illness might be the most probable physiological explanation of the disease because men affected by it have their symptoms dramatically reduced after they undergo hyposensitization therapy via diluted injections of their own sperm akin to hyposensitization therapy done on persons affected by bee venom and peanuts. But more research is yet to be done if post orgasmic illness has only one – or if are there many – variants or if it is just a sperm allergy reaction. 

Post orgasmic illness not only puts a damper on the affected men’s sex lives but also on their jobs as well. A typical man affected by post orgasmic illness whose married and has a 9 to 5, Monday to Friday job schedule can only schedule sex on a Friday night since he could be affected by flu-like symptoms the whole weekend long and he has to report to work on Monday morning to keep a roof over his wife and family’s heads and keep them fed on a day in and day out basis and fund those other extraneous necessities. Due to the rarity of the illness, most healthcare providers only provide coverage to post orgasmic illness via special additional premiums which could add to one’s healthcare expenses. 

Tuesday, June 25, 2013

Should E-Cigarettes Be Classified As A Pharmaceutical Product?



Given the apparent health study results and user’s anecdotal testimony that they are “healthier” than regular tobacco based cigarettes, are there any justification to classify e-cigarettes as a pharmaceutical product? 

By: Ringo Bones

During a recent European Union discussion via the powers-that-be at Brussels on whether to enact proposals to classify e-cigarettes as a pharmaceutical product and to restrict their sale only through pharmacies, may in the EU are now quite surprised on “why now”? After all, e-cigarettes had been freely sold in supermarkets and kiosks that used to sell conventional tobacco based cigarettes for years now. Even Katherine Devlin, head of the Electronic Cigarette Industry Trade Association was quite surprised by the recent proposal by Brussels. 

For those unfamiliar with the product, electronic cigarettes or e-cigarettes turn a nicotine laced liquid into vapor via a built-in battery powered heater. For a number of years it has been used around the world by smokers who are trying to avoid the harmful effects of regular tobacco-based cigarettes – i.e. from the carcinogens found in tobacco like tar, polonium, etc. Given that e-cigarettes for all intents and purposes a way of taking nicotine  - i.e. a nicotine delivery system - for those who are chronically addicted to this tobacco derived alkaloid, shouldn’t e-cigarettes – like other nicotine delivery systems like nicotine patches and gums - be classified as a pharmaceutical product and be sold only in government licensed pharmacies like most tobacco smoking related pharmaceutical products? 

Even tough pro and anti smoking activists are still divided over the long term effects of e-cigarettes, the powers that be in the European Union’s main headquarters at Brussels are proposing for a more stringent health study on the  long-term health effects of e-cigarettes or electronic cigarettes. And also, Adrian Everrett, C.E.O. of e-lites says so far thoughout the world, nobody has yet died of e-cigarette use so far. Though there had been isolated reports of unscrupulous retailers selling e-cigarettes to minors who are not old enough to buy and / or publicly use conventional tobacco cigarettes.